Perceptive Xontogeny Venture Fund, Lp - Net Worth and Insider Trading
Perceptive Xontogeny Venture Fund, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Perceptive Xontogeny Venture Fund, Lp owns 4 companies in total, including Astria Therapeutics Inc (ATXS) , Landos Biopharma Inc (LABP) , and LianBio (LIANY) among others .
Insider Ownership Summary of Perceptive Xontogeny Venture Fund, Lp
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATXS | Astria Therapeutics Inc | 2021-01-28 | director & 10 percent owner |
LABP | Landos Biopharma Inc | 2021-08-27 | director |
LIANY | LianBio | 2021-10-29 | 10 percent owner |
2022-12-02 | director & 10 percent owner |
Perceptive Xontogeny Venture Fund, Lp Trading Performance
Perceptive Xontogeny Venture Fund, Lp Ownership Network
Ownership Network List of Perceptive Xontogeny Venture Fund, Lp
Ownership Network Relation of Perceptive Xontogeny Venture Fund, Lp
Perceptive Xontogeny Venture Fund, Lp Owned Company Details
What does Astria Therapeutics Inc do?
Who are the key executives at Astria Therapeutics Inc?
Perceptive Xontogeny Venture Fund, Lp is the director & 10 percent owner of Astria Therapeutics Inc. Other key executives at Astria Therapeutics Inc include Chief Medical Officer Christopher Morabito , director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Business Officer Andrea Matthews .
Astria Therapeutics Inc (ATXS) Insider Trades Summary
Over the past 18 months, Perceptive Xontogeny Venture Fund, Lp made no insider transaction in Astria Therapeutics Inc (ATXS). Other recent insider transactions involving Astria Therapeutics Inc (ATXS) include a net purchase of 4,295,958 shares made by Perceptive Life Sciences Master Fund Ltd , and a net sale of 20,000 shares made by Christopher Morabito .
In summary, during the past 3 months, insiders sold 0 shares of Astria Therapeutics Inc (ATXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc (ATXS) were sold and 4,295,958 shares were bought by its insiders, resulting in a net purchase of 4,275,958 shares.
Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Astria Therapeutics Inc Insider Transactions
Perceptive Xontogeny Venture Fund, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Perceptive Xontogeny Venture Fund, Lp. You might contact Perceptive Xontogeny Venture Fund, Lp via mailing address: C/o Perceptive Advisors, 51 Astor Place, 10th Floor, New York Ny 10003.